Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options […]
Persistent Inflammation and Cutaneous Dysregulation: Long COVID & Urticaria
Author: John Murphy Affiliation: COVID-19 Long-haul Foundation Introduction The COVID-19 pandemic has left a legacy far beyond acute respiratory illness. For millions worldwide, recovery from SARS-CoV-2 infection has been followed […]
Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction
Ebraheem Albazee • Saad A. Alajmi • et, al., DOI: 10.7759/cureus.94386 Abstract A notable rise in olfactory dysfunction (OD) prevalence has been observed since the COVID-19 pandemic. COVID-19-related OD is associated with several consequences, especially […]
Corticosteroid Strategies in Long COVID: Evaluating Prednisone and Dexamethasone for Persistent Inflammation
John Murphy, The COVID 19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a constellation of symptoms including fatigue, dyspnea, cognitive dysfunction, and systemic […]
Title: Melatonin as a Therapeutic Agent in Long COVID Sleep Disorders: A Multidimensional Review
John Murphy, The Covid-19 Long haul Foundation Abstract Sleep disturbances have emerged as one of the most persistent and debilitating symptoms of Long COVID, affecting up to 76% of patients […]
Pfizer Left COVID-19 Vaccine Data Out Of Submissions To FDA, Documents Show
Data on how parts of a Pfizer-BioNTech COVID-19 vaccine spread in the bodies of mice were withheld from regulatory submissions to the U.S. Food and Drug Administration, according to a new […]
mRNA Vaccination and Arthritis: Etiological Mechanisms, Genomic Susceptibility, Diagnostic Pathways, and Therapeutic Outlook
John Murphy, President The COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have transformed infectious disease prevention, particularly during the COVID-19 pandemic. While their safety profile is robust, emerging evidence […]
Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia
A. Bert Chabot • Margaret P. Huntwork, DOI: 10.7759/cureus.17829 Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused a calamitous perturbation of society worldwide. Anosmia and ageusia (or hyposmia and dysgeusia) have been […]
COVID-19 Discovery Could Spur Treatments for Chronic Lung Problems
Researchers Xiaoqin Wei, PhD, and Jie Sun, PhD, have made a COVID-19 discovery that could open the door to new treatments for the lingering effects of not just COVID but […]
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective
Lucy Kerr • Flavio A. Cadegiani • Fernando Baldi • et. al., DOI: 10.7759/cureus.21272 Abstract Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based […]